Cibus, Inc. (NASDAQ:CBUS – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a decline of 8.7% from the January 15th total of 2,310,000 shares. Based on an average daily trading volume, of 166,400 shares, the days-to-cover ratio is currently 12.7 days. Approximately 10.2% of the shares of the stock are sold short.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. HC Wainwright reiterated a “buy” rating and set a $25.00 price target on shares of Cibus in a report on Monday, November 11th. Canaccord Genuity Group cut their price target on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd.
View Our Latest Research Report on CBUS
Cibus Price Performance
Institutional Investors Weigh In On Cibus
A number of institutional investors have recently added to or reduced their stakes in CBUS. SG Americas Securities LLC bought a new stake in Cibus in the 3rd quarter worth about $33,000. IFP Advisors Inc bought a new stake in Cibus in the 4th quarter worth about $36,000. B. Riley Wealth Advisors Inc. bought a new stake in Cibus in the 3rd quarter worth about $44,000. Virtu Financial LLC bought a new stake in Cibus in the 3rd quarter worth about $48,000. Finally, Sei Investments Co. bought a new stake in Cibus in the 4th quarter worth about $49,000. 33.81% of the stock is owned by institutional investors.
Cibus Company Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Read More
- Five stocks we like better than Cibus
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- What is an Earnings Surprise?
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- 10 Best Airline Stocks to Buy
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.